CD69 antibody - middle region
Rabbit Polyclonal Antibody
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Application
| WB |
---|---|
Primary Accession | Q07108 |
Other Accession | NM_001781, NP_001772 |
Reactivity | Human, Mouse, Rat, Guinea Pig, Dog |
Predicted | Human, Mouse, Rat, Dog |
Host | Rabbit |
Clonality | Polyclonal |
Calculated MW | 22kDa |
Gene ID | 969 |
---|---|
Alias Symbol | CLEC2C, AIM, EA1, MLR-3, GP32/28, BL-AC/P26 |
Other Names | Early activation antigen CD69, Activation inducer molecule, AIM, BL-AC/P26, C-type lectin domain family 2 member C, EA1, Early T-cell activation antigen p60, GP32/28, Leukocyte surface antigen Leu-23, MLR-3, CD69, CD69, CLEC2C |
Format | Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose. |
Reconstitution & Storage | Add 50 ul of distilled water. Final anti-CD69 antibody concentration is 1 mg/ml in PBS buffer with 2% sucrose. For longer periods of storage, store at 20°C. Avoid repeat freeze-thaw cycles. |
Precautions | CD69 antibody - middle region is for research use only and not for use in diagnostic or therapeutic procedures. |
Name | CD69 |
---|---|
Synonyms | CLEC2C |
Function | Involved in lymphocyte proliferation and functions as a signal transmitting receptor in lymphocytes, natural killer (NK) cells, and platelets. |
Cellular Location | Membrane; Single-pass type II membrane protein. |
Tissue Location | Expressed on the surface of activated T-cells, B- cells, natural killer cells, neutrophils, eosinophils, epidermal Langerhans cells and platelets |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
References
Hamann J.,et al.J. Immunol. 150:4920-4927(1993).
Lopez-Cabrera M.,et al.J. Exp. Med. 178:537-547(1993).
Ziegler S.F.,et al.Eur. J. Immunol. 23:1643-1648(1993).
Santis A.,et al.Eur. J. Immunol. 24:1692-1697(1994).
Natarajan K.,et al.Biochemistry 39:14779-14786(2000).
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.